Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107141228 | 10714122 | 8 | F | 2011 | 20160727 | 20150115 | 20160728 | EXP | US-PFIZER INC-2015012548 | PFIZER | 64.00 | YR | F | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107141228 | 10714122 | 1 | PS | LYRICA | PREGABALIN | 1 | 150 MG, 2X/DAY | 21446 | 150 | MG | BID | ||||||||
| 107141228 | 10714122 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Nasal | 1 DF, 2X/DAY, 500/50 MCG, 1 PUFF(S), BID, INHALED | 4ZP2859 | 0 | 1 | DF | INHALATION POWDER | BID | |||||
| 107141228 | 10714122 | 3 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | 4ZP5686 | 0 | INHALATION POWDER | |||||||||
| 107141228 | 10714122 | 4 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 500/50 MCG | 5ZT7759 | 0 | INHALATION POWDER | |||||||||
| 107141228 | 10714122 | 5 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | 6ZP4659 | 0 | INHALATION POWDER | |||||||||
| 107141228 | 10714122 | 6 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | 6ZP4659 | 0 | INHALATION POWDER | |||||||||
| 107141228 | 10714122 | 7 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 PUFF, UNK (1 PUFF(S),500/50 MCG) | 6ZP4659 | 0 | 1 | DF | INHALATION POWDER | |||||||
| 107141228 | 10714122 | 8 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 500/50 MCG, BID | 0 | INHALATION POWDER | BID | |||||||||
| 107141228 | 10714122 | 9 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 10 | C | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 11 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 12 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 13 | C | ATENOLOL. | ATENOLOL | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 14 | C | PREVACID | LANSOPRAZOLE | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 15 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 16 | C | KLONOPIN | CLONAZEPAM | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 17 | C | COLACE | DOCUSATE SODIUM | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 18 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 19 | C | OCUTABS WITH LUTEIN | 2 | UNK | 0 | ||||||||||||
| 107141228 | 10714122 | 20 | C | SOMA | CARISOPRODOL | 1 | UNK | 0 | |||||||||||
| 107141228 | 10714122 | 21 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 107141228 | 10714122 | 22 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 107141228 | 10714122 | 23 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 107141228 | 10714122 | 24 | C | HYDROCODONE | HYDROCODONE | 1 | 0 | ||||||||||||
| 107141228 | 10714122 | 25 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 107141228 | 10714122 | 26 | C | CARISOPRODOL. | CARISOPRODOL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107141228 | 10714122 | 1 | Fibromyalgia |
| 107141228 | 10714122 | 2 | Asthma |
| 107141228 | 10714122 | 3 | Chronic obstructive pulmonary disease |
| 107141228 | 10714122 | 4 | Dyspnoea |
| 107141228 | 10714122 | 5 | Lung disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107141228 | 10714122 | OT |
| 107141228 | 10714122 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107141228 | 10714122 | Bone disorder | |
| 107141228 | 10714122 | Condition aggravated | |
| 107141228 | 10714122 | Dyspnoea | |
| 107141228 | 10714122 | Exostosis | |
| 107141228 | 10714122 | Fall | |
| 107141228 | 10714122 | Fatigue | |
| 107141228 | 10714122 | Hypothyroidism | |
| 107141228 | 10714122 | Large intestine polyp | |
| 107141228 | 10714122 | Limb injury | |
| 107141228 | 10714122 | Loss of consciousness | |
| 107141228 | 10714122 | Mobility decreased | |
| 107141228 | 10714122 | Osteoarthritis | |
| 107141228 | 10714122 | Oxygen saturation decreased | |
| 107141228 | 10714122 | Pain in extremity | |
| 107141228 | 10714122 | Sleep apnoea syndrome | |
| 107141228 | 10714122 | Total lung capacity decreased | |
| 107141228 | 10714122 | Underdose | |
| 107141228 | 10714122 | Upper limb fracture | |
| 107141228 | 10714122 | Vitamin D decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107141228 | 10714122 | 1 | 2011 | 0 | ||
| 107141228 | 10714122 | 2 | 2005 | 0 | ||
| 107141228 | 10714122 | 4 | 2010 | 0 | ||
| 107141228 | 10714122 | 7 | 201001 | 0 | ||
| 107141228 | 10714122 | 8 | 2010 | 0 | ||
| 107141228 | 10714122 | 14 | 201603 | 0 |